Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
COGT
#1198
Cogent Biosciences, Inc. Common Stock
36.490
0
USD
-0.08%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
-0.08%
Aylık Değişim
-0.82%
6 aylık değişim
+132.87%
Yıllık Değişim
+132.87%
Önceki Kapanış
36.520
0
Open
36.490
0
Bid
Ask
Low
36.490
0
High
36.490
0
Hacim
155
Piyasalar
ABD Borsası
Sağlık Hizmetleri
COGT
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
37.19 M
45.81 M
69.95 M
103.91 M
113.85 M
162.31 M
—
Valuation ratios
Enterprise value
175.5 M
173.4 M
700.25 M
595.19 M
789.87 M
5.69 B
9.16 B
Price to earnings ratio
—
—
-4.63
-2.58
-4.02
-16.44
-29.39
Price to sales ratio
—
—
248.09
523.23
—
-637.59
—
Price to cash flow ratio
—
—
-5.48
-3.24
-3.9
-17.31
-30.43
Price to book ratio
—
—
3.42
1.93
3.16
7.19
10.37
Enterprise value to EBITDA ratio
—
—
-4.77
-2.8
-2.81
-16.07
—
Profitability ratios
Return on assets %
-0.3
-0.31
-0.47
-0.61
-0.78
-0.35
-0.82
Return on equity %
-0.32
-0.34
-0.55
-0.75
-1
-0.52
-1.23
Return on invested capital %
-2 246.8
-1 790.94
-1 694.11
-1 510.27
-1 804.19
-2 191.25
—
Gross margin %
100
100
100
100
—
100
—
Operating margin %
-1 044.33
-3 061.22
-5 640.56
-21.91 K
—
4 642.29
—
EBITDA margin %
—
—
-5 603.05
-22.35 K
—
4 725.54
—
Net margin %
-950.43
-2 928.4
-5 350.67
-20.25 K
—
4 580.66
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
18.7
13.04
9.87
7.09
5.32
14.23
29.94
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.05
0.01
0.01
0
0
-0.01
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
0.25
—
Debt to equity ratio
—
—
—
—
—
0.38
—
Long term debt to total assets ratio
—
—
—
—
—
0.24
—
Long term debt to total equity ratio
—
—
—
—
—
0.35
—
Per share metrics
Operating cash flow per share
—
—
-2.02
-1.93
-2
-2.05
-2.2
EBIT per share
—
—
-2.47
-2.6
-2.66
-2.64
—
EBITDA per share
—
—
-2.5
-2.67
-2.71
-2.63
—
Total debt per share
—
—
—
—
—
1.85
—
Cash per share
—
—
4.41
3.34
2.76
6.99
14.44
Net current asset value per share
—
—
4.51
3.4
2.85
7.06
14.69
Tangible book value per share
—
—
3.23
3.24
2.47
4.94
10.42
Working capital per share
—
—
4.05
2.92
2.32
6.57
12.74
Book value per share
—
—
3.23
3.24
2.47
4.94
10.71
Haberler
Cogent Biosciences: Blockbuster Potential, Premium Valuation, Still A 'Buy' (NASDAQ:COGT)
H.C. Wainwright, Cogent hissesi için tavsiyesini korudu
Fairmount Funds, Cogent Biosciences hisselerini 242,6 milyon dolara sattı
En İyi SMID Biyoteknoloji Hisseleri: Jefferies’in 3 Tercihi
COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM
Raymond James, Cogent hissesi için Güçlü Al tavsiyesini korudu
Raymond James reiterates Cogent stock Strong Buy on FDA filing acceptance
Cogent Biosciences: Trio Of Approvals Beckon For Lead Drug - Still Bullish (NASDAQ:COGT)
Piper Sandler, ilaç lansmanı görünümü nedeniyle Cogent hisse fiyat hedefini yükseltti
Why Is Pfizer Stock Rising Tuesday? - Pfizer (NYSE:PFE)
Cogent Biosciences hisseleri FDA’nın çığır açan tedavi statüsü vermesiyle yükseldi
Cogent Biosciences stock rises after FDA grants breakthrough therapy status